Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Celecoxib: safety and efficacy data presented at rheumatology meeting

Nov. 17, 1997

T-614, a new NSAID that appears to act as a lysosomal protease inhibitor

Nov. 14, 1997

KE-298 suppresses MMP production in RA synoviocytes

Nov. 14, 1997

Selective collagenase 3 inhibitor shows promise for osteoarthritis

Nov. 14, 1997

Preclinical antiinflammatory effects demonstrated for CT-3

Nov. 13, 1997

Minocycline associated with marked long-term efficacy in early RA

Nov. 13, 1997

Promising clinical results reported for Avakine

Nov. 13, 1997

New class of TNF-alpha inhibitors safe and well tolerated in phase I

Nov. 12, 1997

rhIL-1ra provides long-term improvement in RA

Nov. 11, 1997

Clinical results reported for leflunomide in refractory RA and Wegener's granulomatosis

Nov. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...